Issue 9, 2022

Risk assessment and data gap filling of toxicity of metal oxide nanoparticles (MeOx NPs) used in nanomedicines: a mechanistic QSAR approach

Abstract

Nanotechnology has become a fast-growing area of science. Recently, there has been an increase in the use of metal oxide nanoparticles (MeOx NPs) due to their unique morphology and physical properties. The application of MeOx NPs in nanomedicines has opened up new perspectives for medical devices and development in health care. Nanomedicines and nanotoxicity are complementary to each other. Lack of sufficient data and low-adequacy experimental setups obstruct the assessment of their potential risk to human cells. Regulatory authorities have also encouraged the application of the quantitative structure–activity relationship (QSAR) approach towards the safe design of nano-based products. Therefore, in the present computational study, multiple linear regression (MLR) modeling with 16 MeOx NP datasets and partial least squares (PLS) regression modeling with 15 MeOx NP datasets (117 data points with different physical features and conditions) were performed to determine the cytotoxicity of NPs towards HaCaT cells. Easily interpretable periodic table descriptors (1st and 2nd generation) and some previously reported physical descriptors were employed for modeling. The genetic algorithm (GA) followed by best subset selection (BSS) technique was applied before the model development. The final MLR model (4 descriptors) and PLS (2 LVs) model for the two datasets was rigorously validated with various stringent validation criteria following the strict Organisation for Economic Co-operation and Development (OECD) guidelines. The statistical data of the MLR model (Q(LOO)2 = 0.83, R2 = 0.95) and PLS model (Q(LOO)2 = 0.73, R2 = 0.76) were robust and reliable. Features like electronegativity, formation of a metal cation, increase in solubility, and dose were important for the mechanism of toxicity. Therefore, these models can be efficient tools for designing modern materials with optimal properties and minimal potential toxicity.

Graphical abstract: Risk assessment and data gap filling of toxicity of metal oxide nanoparticles (MeOx NPs) used in nanomedicines: a mechanistic QSAR approach

Supplementary files

Article information

Article type
Paper
Submitted
29 Mar 2022
Accepted
18 Jul 2022
First published
20 Jul 2022

Environ. Sci.: Nano, 2022,9, 3456-3470

Risk assessment and data gap filling of toxicity of metal oxide nanoparticles (MeOx NPs) used in nanomedicines: a mechanistic QSAR approach

J. Roy and K. Roy, Environ. Sci.: Nano, 2022, 9, 3456 DOI: 10.1039/D2EN00303A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements